On the other hand, the data presented by Kaynar et al. [18] showed that the erythrocyte SOD1 activity was significantly higher in patients with lung cancer than in the control group and, interestingly, significantly higher in stage III–IV than stage I–II. This evidence concerns the gene SOD1 and lung carcinoma.